Lip GYH - Search Results

1

Blood glucose reduction by diabetic drugs with minimal hypoglycaemia risk for cardiovascular outcomes: Evidence from meta-regression analysis of randomized controlled trials.

Huang CJ, Wang WT, Sung SH, Chen CH, Lip GYH, Cheng HM, Chiang CE. Huang CJ, et al. Among authors: lip gyh. Diabetes Obes Metab. 2018 Sep;20(9):2131-2139. doi: 10.1111/dom.13342. Epub 2018 May 29. Diabetes Obes Metab. 2018. PMID: 29722116

2

Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and -2 in type 2 diabetes: effect of 1 year's cardiovascular risk reduction therapy.

Tayebjee MH, Lim HS, MacFadyen RJ, Lip GY. Tayebjee MH, et al. Diabetes Care. 2004 Aug;27(8):2049-51. doi: 10.2337/diacare.27.8.2049. Diabetes Care. 2004. PMID: 15277439 No abstract available.

3

Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention.

Lim HS, Blann AD, Chong AY, Freestone B, Lip GY. Lim HS, et al. Diabetes Care. 2004 Dec;27(12):2918-24. doi: 10.2337/diacare.27.12.2918. Diabetes Care. 2004. PMID: 15562207

4

Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis.

Rasmussen LH, Larsen TB, Graungaard T, Skjøth F, Lip GY. Rasmussen LH, et al. BMJ. 2012 Nov 5;345:e7097. doi: 10.1136/bmj.e7097. BMJ. 2012. PMID: 23129490 Free PMC article.

5

Stroke prevention in atrial fibrillation: an Asian perspective.

Chiang CE, Wang KL, Lip GY. Chiang CE, et al. Thromb Haemost. 2014 May 5;111(5):789-97. doi: 10.1160/TH13-11-0948. Epub 2014 Feb 6. Thromb Haemost. 2014. PMID: 24500243 Review.

6

Renal function and non-vitamin K oral anticoagulants in comparison with warfarin on safety and efficacy outcomes in atrial fibrillation patients: a systemic review and meta-regression analysis.

Nielsen PB, Lane DA, Rasmussen LH, Lip GY, Larsen TB. Nielsen PB, et al. Clin Res Cardiol. 2015 May;104(5):418-29. doi: 10.1007/s00392-014-0797-9. Epub 2014 Nov 22. Clin Res Cardiol. 2015. PMID: 25416564 Review.

7

Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: time for a reappraisal.

Lip GY, Wang KL, Chiang CE. Lip GY, et al. Int J Cardiol. 2015 Feb 1;180:246-54. doi: 10.1016/j.ijcard.2014.11.182. Epub 2014 Nov 26. Int J Cardiol. 2015. PMID: 25463377 Free article. Review.

8

Non-vitamin K antagonist oral anticoagulants and the treatment of venous thromboembolism in cancer patients: a semi systematic review and meta-analysis of safety and efficacy outcomes.

Larsen TB, Nielsen PB, Skjøth F, Rasmussen LH, Lip GY. Larsen TB, et al. PLoS One. 2014 Dec 5;9(12):e114445. doi: 10.1371/journal.pone.0114445. eCollection 2014. PLoS One. 2014. PMID: 25479007 Free PMC article. Review.

9

Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors--Results from a systematic review and meta-analysis of randomized controlled trials.

Sahebkar A, Serban C, Ursoniu S, Wong ND, Muntner P, Graham IM, Mikhailidis DP, Rizzo M, Rysz J, Sperling LS, Lip GY, Banach M; Lipid and Blood Pressure Meta-analysis Collaboration Group. Sahebkar A, et al. Int J Cardiol. 2015;189:47-55. doi: 10.1016/j.ijcard.2015.04.008. Epub 2015 Apr 1. Int J Cardiol. 2015. PMID: 25885871 Review.

10

Asymptomatic versus symptomatic atrial fibrillation: A systematic review of age/gender differences and cardiovascular outcomes.

Xiong Q, Proietti M, Senoo K, Lip GY. Xiong Q, et al. Int J Cardiol. 2015 Jul 15;191:172-7. doi: 10.1016/j.ijcard.2015.05.011. Epub 2015 May 7. Int J Cardiol. 2015. PMID: 25974193 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,432 results

Search Page